← Back to Search

Depression Care Management for Depression

N/A
Waitlist Available
Led By Martha L Bruce, PhD, MPH
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 65 years or older
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights

Study Summary

This trial found that the Depression CAREPATH intervention worked in reducing depression symptoms in older home healthcare patients.

Who is the study for?
This trial is for home healthcare patients aged 65 or older who are experiencing depression, can communicate in English or Spanish, and have been noted to have a depressed mood. It's not suitable for those with significant cognitive issues, very short life expectancy, high suicide risk, or severe communication difficulties due to hearing loss.Check my eligibility
What is being tested?
The study is examining the 'Depression CAREPATH' initiative against usual care practices. The CAREPATH aims to improve how nurses help manage depression treatment over time with patient and doctor collaboration. Patient progress will be tracked at several intervals up to one year.See study design
What are the potential side effects?
Since this trial involves care management rather than medication, side effects are not typical as with drug trials. However, there may be emotional or psychological impacts from discussing depressive symptoms regularly.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Depression Severity
Secondary outcome measures
Guideline Consistent change in depression treatment

Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
Patients under the care of nurses who were trained in depression assessment and usual care
Group II: Depression CAREPATHExperimental Treatment1 Intervention
Patients receiving care from Nurses trained in depression care management

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,054 Previous Clinical Trials
1,316,218 Total Patients Enrolled
66 Trials studying Depression
16,088 Patients Enrolled for Depression
Martha L Bruce, PhD, MPHPrincipal InvestigatorWeill Medical College of Cornell University
2 Previous Clinical Trials
7,889 Total Patients Enrolled
1 Trials studying Depression
7,800 Patients Enrolled for Depression

Media Library

Depression CAREPATH Clinical Trial Eligibility Overview. Trial Name: NCT01979302 — N/A
Depression Research Study Groups: Depression CAREPATH, Usual Care
Depression Clinical Trial 2023: Depression CAREPATH Highlights & Side Effects. Trial Name: NCT01979302 — N/A
Depression CAREPATH 2023 Treatment Timeline for Medical Study. Trial Name: NCT01979302 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new participants being sought for this research endeavor?

"The details shared on clinicaltrials.gov suggest that the recruitment phase has ended for this trial, with its last update being posted back in July 2014. Nevertheless, there are currently 1288 other medical studies welcoming new patients."

Answered by AI
Recent research and studies
~19 spots leftby Apr 2025